Prostacyclin receptor-mediated activation of extracellular signal-regulated kinases 1 and 2

Kit Man Chu1, Kevin B S Chow, Yung H Wong

  • 1Department of Pharmacology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong S.A.R, China.

Cellular Signalling
|January 8, 2004
PubMed

Insights

The prostacyclin mimetic cicaprost activates extracellular signal-regulated kinases 1 and 2 (ERK1/2) in cells with prostacyclin receptors. This activation involves protein kinase C and phosphoinositide 3-kinase, independent of cyclic AMP.

Area of Science:

  • Cellular signaling pathways
  • Molecular pharmacology
  • Receptor-mediated signal transduction

Background:

  • Prostacyclin receptors (IP receptors) mediate cellular responses to prostacyclin and its analogs.
  • Extracellular signal-regulated kinases (ERK1/2) are key components of intracellular signaling cascades.
  • Understanding IP receptor signaling is crucial for developing targeted therapeutics.

Purpose of the Study:

  • To investigate the signaling mechanisms by which cicaprost activates ERK1/2 in cells expressing prostacyclin receptors.
  • To determine the role of cyclic AMP (cAMP) and other signaling pathways in this activation.
  • To compare signaling in cells with transiently expressed versus endogenously expressed IP receptors.

Main Methods:

  • Transiently transfecting Chinese hamster ovary (CHO) cells with human (hIP-CHO) or mouse (mIP-CHO) prostacyclin receptors.
  • Treating cells with cicaprost and measuring ERK1/2 phosphorylation.
  • Utilizing protein kinase C inhibitors and agents that modulate cyclic AMP levels.
  • Assessing the correlation between ERK1/2 activity and cyclic AMP production.

Main Results:

  • Cicaprost increased ERK1/2 phosphorylation in hIP-CHO and mIP-CHO cells (EC50 values 60 and 83 nM, respectively).
  • This activation was inhibited by protein kinase C inhibitors and agents that elevate cyclic AMP.
  • A weak correlation was observed between ERK1/2 activity and cyclic AMP modulation.
  • 3-isobutyl-1-methylxanthine inhibited cicaprost-stimulated phospho-ERK1/2, suggesting phosphoinositide 3-kinase involvement.

Conclusions:

  • IP receptor-mediated ERK1/2 activation in CHO cells is dependent on Gq/11 and protein kinase C.
  • Phosphoinositide 3-kinase plays a role in this signaling pathway.
  • The activation of ERK1/2 by IP receptors in this context is insensitive to cyclic AMP levels generated by the receptor.

Related Concept Videos

Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...